標(biāo)題: Titlebook: Essentials of Non-Alcoholic Fatty Liver Disease; Complications and Ex Anca Trifan,Carol Stanciu,Cristina Muzica Book 2023 The Editor(s) (if [打印本頁] 作者: Conformist 時(shí)間: 2025-3-21 16:50
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease影響因子(影響力)
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease影響因子(影響力)學(xué)科排名
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease網(wǎng)絡(luò)公開度
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease被引頻次
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease被引頻次學(xué)科排名
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease年度引用
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease年度引用學(xué)科排名
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease讀者反饋
書目名稱Essentials of Non-Alcoholic Fatty Liver Disease讀者反饋學(xué)科排名
作者: Silent-Ischemia 時(shí)間: 2025-3-21 23:36
Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease,prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to H作者: Mangle 時(shí)間: 2025-3-22 00:29 作者: Deceit 時(shí)間: 2025-3-22 05:42 作者: 決定性 時(shí)間: 2025-3-22 10:07
Alternative Methods for Liver Biopsy: Endoscopic Ultrasound-Guided and Transjugular Liver Biopsy,r the positive diagnosis of patients with nonalcoholic fatty liver disease and steatohepatitis. Conventional transabdominal liver biopsy has been embraced by many as the standard technique; nevertheless, alternative methods for liver biopsy have been developed among which endoscopic ultrasound-guide作者: averse 時(shí)間: 2025-3-22 16:20 作者: averse 時(shí)間: 2025-3-22 20:48
2D Shear Wave Elastography Performance in the Diagnosis of Nonalcoholic Fatty Liver Disease,ral population. The evaluation of liver fibrosis severity in NAFLD is very important for the prognosis stratification and modulation of therapeutic interventions. Ultrasound-based elastography developed rapidly, due to its applications in multiple liver pathologies, being easily accepted by patients作者: 得罪人 時(shí)間: 2025-3-22 22:50
Vibration-Controlled Transient Elastography and Controlled Attenuation Parameter for Staging Nonalcto numerous liver-related complications if it progresses to nonalcoholic steatohepatitis (NASH). Noninvasive testing has been investigated for the purposes of diagnosis, risk stratification, disease progression, and determining therapeutic response. In recent years, quantitative ultrasound imaging m作者: 情感 時(shí)間: 2025-3-23 03:19 作者: CIS 時(shí)間: 2025-3-23 05:36
Pathophysiology and Risk Stratification in Cardiovascular Diseases and NAFLD,lipoprotein dysfunction, and gut dysbiosis determine a chronic inflammatory response associated with endothelial dysfunction, procoagulant status, and increased cardiovascular risk. NAFLD is associated with an increased risk of ischemic heart disease in direct relation to liver fibrosis severity. NA作者: 刺穿 時(shí)間: 2025-3-23 12:29
Type 2 Diabetes Mellitus and Insulin Resistance in Nonalcoholic Fatty Liver Disease,mmon links, from epidemiology to diagnosis and prognosis. The common pathophysiological mechanisms are incompletely known, but insulin resistance (IR) plays a major role. The presence of T2DM in patients with NAFLD increases the progression towards fibrosis and hepatocellular carcinoma. On the other作者: 推測 時(shí)間: 2025-3-23 14:44 作者: 休閑 時(shí)間: 2025-3-23 18:55
Endocrinopathies in Nonalcoholic Fatty Liver Disease, worldwide. Recent studies have demonstrated that there is a bidirectional relationship between the development, progression, and severity of NAFLD and various endocrine disorders such as hypothyroidism, hypopituitarism, growth hormone deficiency, hyperprolactinemia, hypercortisolism, polycystic ova作者: candle 時(shí)間: 2025-3-23 22:21 作者: 時(shí)代錯(cuò)誤 時(shí)間: 2025-3-24 03:13
Psychological Burden of NAFLD and Psychiatric Disorders as Extrahepatic Manifestations, global health burden worldwide. NAFLD includes the progressive disease spectrum from simple steatosis through nonalcoholic steatohepatitis (NASH) to liver cirrhosis and hepatocarcinoma. Morbimortality is linked to the liver disease itself and to extrahepatic complications related to NAFLD and metab作者: 笨拙處理 時(shí)間: 2025-3-24 07:53
Obstructive Sleep Apnea Syndrome and Nonalcoholic Fatty Liver Disease,g prevalence worldwide. Recent data from the literature established that obstructive sleep apnea and chronic intermittent hypoxia (CIH) are risk factors for the progression of NAFLD. However, it is challenging to determine the effects of OSA on the development and progression of NAFLD and vice versa作者: CIS 時(shí)間: 2025-3-24 14:12 作者: panorama 時(shí)間: 2025-3-24 18:25 作者: 飲料 時(shí)間: 2025-3-24 19:20 作者: Preamble 時(shí)間: 2025-3-25 01:16
https://doi.org/10.1057/9780230801516prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to H作者: 小教堂 時(shí)間: 2025-3-25 04:06 作者: pus840 時(shí)間: 2025-3-25 10:57
https://doi.org/10.1057/9780230277052 noninvasive methods based on blood tests and advanced imaging techniques such as vibration-controlled transient elastography, 2D shear wave elastography, and acoustic radiation force impulse, with a high accuracy and low costs. However, the liver biopsy (LB) has been used as a standard for diagnosi作者: Harness 時(shí)間: 2025-3-25 14:58
Corporate Security Surveillancer the positive diagnosis of patients with nonalcoholic fatty liver disease and steatohepatitis. Conventional transabdominal liver biopsy has been embraced by many as the standard technique; nevertheless, alternative methods for liver biopsy have been developed among which endoscopic ultrasound-guide作者: 挑剔為人 時(shí)間: 2025-3-25 18:04 作者: notion 時(shí)間: 2025-3-25 23:53 作者: Nucleate 時(shí)間: 2025-3-26 03:46
,Schritt 6: überwachung der Konsequenzen,to numerous liver-related complications if it progresses to nonalcoholic steatohepatitis (NASH). Noninvasive testing has been investigated for the purposes of diagnosis, risk stratification, disease progression, and determining therapeutic response. In recent years, quantitative ultrasound imaging m作者: 幻影 時(shí)間: 2025-3-26 08:01 作者: Receive 時(shí)間: 2025-3-26 09:36 作者: 策略 時(shí)間: 2025-3-26 14:54 作者: COKE 時(shí)間: 2025-3-26 18:49 作者: 裁決 時(shí)間: 2025-3-26 21:41 作者: allergy 時(shí)間: 2025-3-27 03:48
https://doi.org/10.1007/978-3-319-35083-7malignancies. Due to its frequent association with metabolic syndrome, NAFLD is considered a multisystemic disease, and it is a cause of many non-liver-related malignancies such as colorectal, esophageal, gastric, pancreatic, kidney, and breast cancer. The aim of this review is to summarize the extr作者: 等級的上升 時(shí)間: 2025-3-27 08:41
Corporate Social Responsibility global health burden worldwide. NAFLD includes the progressive disease spectrum from simple steatosis through nonalcoholic steatohepatitis (NASH) to liver cirrhosis and hepatocarcinoma. Morbimortality is linked to the liver disease itself and to extrahepatic complications related to NAFLD and metab作者: 沒有準(zhǔn)備 時(shí)間: 2025-3-27 11:21 作者: 勉強(qiáng) 時(shí)間: 2025-3-27 14:24 作者: 使無效 時(shí)間: 2025-3-27 18:30
http://image.papertrans.cn/e/image/315673.jpg作者: 欺騙手段 時(shí)間: 2025-3-27 22:10 作者: Bernstein-test 時(shí)間: 2025-3-28 05:36 作者: 激怒 時(shí)間: 2025-3-28 08:55
https://doi.org/10.1057/9780230801516prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to HCC in the absence of cirrhosis.作者: 減弱不好 時(shí)間: 2025-3-28 13:46
Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease,prevalence appears to be increasing and is related to the widespread problem of obesity in the entire world..NAFLD can potentially progress to advanced liver disease: cirrhosis and hepatocellular carcinoma (HCC). Recent evidence has shown a significant proportion of patients with NAFLD progress to HCC in the absence of cirrhosis.作者: 絕緣 時(shí)間: 2025-3-28 14:58
Endocrinopathies in Nonalcoholic Fatty Liver Disease,rian syndrome, and hypogonadism. Treatment of the endocrine disorder may alter the overall prognosis of NAFLD. Awareness and appropriate surveillance and treatment are key issues for best patients’ care and outcome.作者: 哭得清醒了 時(shí)間: 2025-3-28 21:28 作者: 沖突 時(shí)間: 2025-3-29 00:55 作者: 微粒 時(shí)間: 2025-3-29 03:23
B?rte?in Ege,Bernhard Humm,Anatol Reiboldonic liver diseases of different etiologies. 2D-SWE techniques are proved to be reliable also for the evaluation of liver fibrosis in NAFLD patients, and the guidelines recommend to use them especially for ruling out liver cirrhosis.作者: Nebulizer 時(shí)間: 2025-3-29 08:09 作者: 是突襲 時(shí)間: 2025-3-29 11:48 作者: 祖先 時(shí)間: 2025-3-29 17:00
es details on the pathophysiological mechanisms in NAFLD and.The book is a compact yet comprehensive practical resource that highlights all must-know information on non-alcoholic fatty liver disease (NAFLD).?.Covering the major issues dominating the field, this book offers a broad vision on NAFLD us作者: 思鄉(xiāng)病 時(shí)間: 2025-3-29 21:03 作者: 幼兒 時(shí)間: 2025-3-30 02:34
https://doi.org/10.1007/978-3-319-35083-7r-related malignancies such as colorectal, esophageal, gastric, pancreatic, kidney, and breast cancer. The aim of this review is to summarize the extrahepatic malignancies associated with NAFLD. Further studies and rigorous surveillance programs are needed in NAFLD patients in order to decrease all-cause mortality.作者: 充滿裝飾 時(shí)間: 2025-3-30 07:36
https://doi.org/10.1007/978-981-10-4266-9 of genetic and epigenetic factors becoming crucial in drawing new directives regarding managing patients at risk of developing NAFLD, its treatment, and reversibility pathways of the characteristic liver lesions.作者: 協(xié)議 時(shí)間: 2025-3-30 09:39
Schlussbetrachtung und Ausblick,he defining element for identifying the therapeutic targets common to the two conditions. In this chapter, we review the epidemiological data, the pathophysiological mechanisms, and the consequences of the association of T2DM and NAFLD. The practical approach will focus on the particular diagnostic methods and therapies common to both conditions.作者: 消極詞匯 時(shí)間: 2025-3-30 14:56
Genetics and Epigenetics in Nonalcoholic Fatty Liver Disease, of genetic and epigenetic factors becoming crucial in drawing new directives regarding managing patients at risk of developing NAFLD, its treatment, and reversibility pathways of the characteristic liver lesions.作者: 閑逛 時(shí)間: 2025-3-30 19:47
Type 2 Diabetes Mellitus and Insulin Resistance in Nonalcoholic Fatty Liver Disease,he defining element for identifying the therapeutic targets common to the two conditions. In this chapter, we review the epidemiological data, the pathophysiological mechanisms, and the consequences of the association of T2DM and NAFLD. The practical approach will focus on the particular diagnostic methods and therapies common to both conditions.作者: 陳腐的人 時(shí)間: 2025-3-30 23:56 作者: 事與愿違 時(shí)間: 2025-3-31 04:51 作者: 不如屎殼郎 時(shí)間: 2025-3-31 06:42 作者: LATE 時(shí)間: 2025-3-31 12:11 作者: 遷移 時(shí)間: 2025-3-31 15:21 作者: 背心 時(shí)間: 2025-3-31 21:00
The Place of Transabdominal Liver Biopsy in Nonalcoholic Fatty Liver Disease,patitis from simple steatosis and determining the stage of fibrosis is still liver histology. Thus, LB remains an important diagnostic tool, particularly in patients with NASH in which the diagnosis as well as the staging of the disease is difficult to be done with only the use of noninvasive tests.作者: Afflict 時(shí)間: 2025-4-1 00:35 作者: cacophony 時(shí)間: 2025-4-1 04:06 作者: Exposition 時(shí)間: 2025-4-1 09:17 作者: Forehead-Lift 時(shí)間: 2025-4-1 13:04
Nonalcoholic Fatty Liver Disease Within Other Causes of Chronic Liver Diseases,e secondary to metabolic syndrome and obesity, respectively. However, the distinction between the two entities is often difficult..Diagnosing the presence of a dual etiology of liver disease in the subgroup of patients with NAFLD should lead to a multidisciplinary approach for targeted therapy as we作者: Intentional 時(shí)間: 2025-4-1 16:27
